BioInn_CIEMAT's profile picture. Cuenta oficial de la Unidad de Innovación Biomédica del CIEMAT.
También estamos en Instagram: bioinn_ciemat y LinkedIn: Unidad Innovación Biomédica CIEMAT.

CIEMAT Innovación Biomédica

@BioInn_CIEMAT

Cuenta oficial de la Unidad de Innovación Biomédica del CIEMAT. También estamos en Instagram: bioinn_ciemat y LinkedIn: Unidad Innovación Biomédica CIEMAT.

🎉We are happy to share with you a recent paper from a collaboration between Dr García-Escudero and Dr Lorz and Cancerappy about DrugAppy: an end-to-end deep learning framework for drug discovery. Go to check it at: sciencedirect.com/science/articl…

BioInn_CIEMAT's tweet image. 🎉We are happy to share with you a recent paper from a collaboration between Dr García-Escudero and Dr  Lorz and Cancerappy about DrugAppy: an end-to-end deep learning framework for drug discovery. Go to check it at:
sciencedirect.com/science/articl…

📢🎉 We’re proud to announce a new publication from Andrea López and colleagues in Dr. José Antonio Casado’s lab, describing a novel CAR-T cell therapy for head and neck squamous cell carcinoma in Fanconi Anemia. 🔗Read the full paper: sciencedirect.com/science/articl…


✨ Paper of the week! A new gene-editing approach for Primary Hyperoxaluria Type 1 (PH1) by Zhang and colleagues. Curious about how it works? Discover more here 👇 🔗 link.springer.com/article/10.100…


🚀 Our Biomedical Innovation Unit keeps sharing insights, papers & achievements across platforms! Follow us on Instagram @bioinn_ciemat and LinkedIn (Unidad de Innovación Biomédica CIEMAT) to stay tuned! 🔬✨


🎉We are happy to share with you a recent paper published by Dr. Isabel Ojeda and colleagues from Dr. Jose Carlos Segovia’s lab about a new gene editing strategy in Pyruvate Kinase Deficiency (PKD) model. Go check it at cell.com/molecular-ther…

BioInn_CIEMAT's tweet image. 🎉We are happy to share with you a recent paper published by Dr. Isabel Ojeda and colleagues from Dr. Jose Carlos Segovia’s lab about a new gene editing strategy in Pyruvate Kinase Deficiency (PKD) model. Go check it at cell.com/molecular-ther…

🎉🎉During the ESGCT & SETGYC Congress held in Seville, our Head of Unit, Professor Dr. Juan Bueren, has been awarded the Outstanding Achievement Award for his career in the field of gene therapy for patients with Fanconi Anemia, @CIEMAT_OPI @ESGCT @SETGyC

BioInn_CIEMAT's tweet image. 🎉🎉During the ESGCT & SETGYC Congress held in Seville, our Head of Unit, Professor Dr. Juan Bueren, has been awarded the Outstanding Achievement Award for his career in the field of gene therapy for patients with Fanconi Anemia, @CIEMAT_OPI @ESGCT @SETGyC

CIEMAT Innovación Biomédica 已轉發

Data from the second human treated with a prime edited medicine: a 56-year-old male with chronic granulotamous disease (CGD) had his bone marrow prime edited to insert the missing GT in NCF1, restoring NADPH oxidase function in neutrophils (DHR positivity) several fold beyond the…

davidrliu's tweet image. Data from the second human treated with a prime edited medicine: a 56-year-old male with chronic granulotamous disease (CGD) had his bone marrow prime edited to insert the missing GT in NCF1, restoring NADPH oxidase function in neutrophils (DHR positivity) several fold beyond the…

CIEMAT Innovación Biomédica 已轉發

👩‍🔬🧑‍🔬Investigadores del @CIEMAT_OPI @BioInn_CIEMAT logran un avance clave en #terapia #genética para la epidermólisis ampollosa distrófica, una #enfermedadrara de la piel. 👉Este trabajo se acaba de publicar en la prestigiosa revista Human Gene Therapy @LiebertPub, en…

CIEMAT_OPI's tweet image. 👩‍🔬🧑‍🔬Investigadores del @CIEMAT_OPI @BioInn_CIEMAT  logran un avance clave en #terapia #genética para la epidermólisis ampollosa distrófica, una #enfermedadrara de la piel.

👉Este trabajo se acaba de publicar en la prestigiosa revista Human Gene Therapy @LiebertPub, en…

Loading...

Something went wrong.


Something went wrong.